Income Statement China Renaissance Holdings Limited

Stocks

1911

KYG212151016

Investment Banking & Brokerage Services

Market Closed - Hong Kong S.E. 01:38:14 23/09/2026 pm IST			5-day change	1st Jan Change
3.670 ^HKD	-2.00%		-0.81%	-11.14%

21/09	China Renaissance's Unit Advises AI Company on Series B+, Series C Fundraising	MT
27/08	China Renaissance Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2026	CI

ce.we37KbsKbdmeu4rPP_WeWKF_-FZixHGN9Q4tRkpNFL8.nqi5Z_M6C42piueDcLqrKc4pmSYnkED_oEt6c3g3X5KVpplI9kQEodvasg

Published financial data: CHINA RENAISSANCE HOLDINGS LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Interest and Dividend Income, Total	7.5Cr	7.51Cr	8.49Cr	4.41Cr	4.24Cr
Interest Expense, Total	11Cr	11Cr	5.06Cr	1.61Cr	1.15Cr
Net Interest Income	-3.75Cr	-3.73Cr	3.43Cr	2.8Cr	3.09Cr
Asset Management Fee	44Cr	53Cr	46Cr	30Cr	21Cr
Underwriting & Investment Banking Fee	119.85Cr	58Cr	31Cr	33Cr	29Cr
Gain (Loss) on Sale of Investments, Total (Rev)	76Cr	15.09L	-21Cr	6.25Cr	13Cr
Other Revenues, Total	2.88Cr	40Cr	15Cr	10Cr	52Cr
Revenues Before Provison For Loan Losses	239.15Cr	147.44Cr	75Cr	82Cr	118.66Cr
Provision For Loan Losses	3.76Cr	12Cr	2.45Cr	-	-5.76Cr
Total Revenues	235.39Cr	135.88Cr	72Cr	82Cr	124.42Cr
Salaries And Other Employee Benefits	109.93Cr	75Cr	48Cr	49Cr	44Cr
Cost of Services Provided, Total	6L	10L	23.9L	7L	66T
Provision for Bad Debts	73.22L	3.83Cr	-2.82Cr	-24.14L	53T
Other Operating Expenses	38Cr	61Cr	47Cr	43Cr	67Cr
Total Operating Expenses	149Cr	140.57Cr	92Cr	91Cr	110.86Cr
Operating Income	86Cr	-4.69Cr	-20Cr	-8.99Cr	14Cr
Income (Loss) on Equity Invest.	-1.44Cr	-62.44L	13.86L	5L	-
Currency Exchange Gains (Loss)	42.55L	-5.33Cr	-72.48L	-12.08L	44.99L
Other Non Operating Income (Expenses)	99Cr	1.78Cr	-8.44Cr	5.39Cr	2.93Cr
EBT, Excl. Unusual Items	184.03Cr	-8.86Cr	-29Cr	-3.67Cr	17Cr
Gain (Loss) on Sale of Investments	1.7Cr	-20Cr	-2.77Cr	-14Cr	3T
Gain (Loss) on Sale of Assets	-	-48T	-28T	4T	-55T
Asset Writedown	-	-	-	-47.01L	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-14.61L	-9.07Cr	-2.42Cr	2.19Cr	-74.49L
EBT, Incl. Unusual Items	185.59Cr	-38Cr	-34Cr	-16Cr	16Cr
Income Tax Expense	21Cr	7.1Cr	12Cr	4.81Cr	6.96Cr
Earnings From Continuing Operations	164.54Cr	-45Cr	-46Cr	-21Cr	9.23Cr
Net Income to Company	164.54Cr	-45Cr	-46Cr	-21Cr	9.23Cr
Minority Interest	-2.1Cr	2.41Cr	-1.09Cr	3.16Cr	90.71L
Net Income - (IS)	162.44Cr	-43Cr	-47Cr	-18Cr	10Cr
Net Income to Common Incl Extra Items	162.44Cr	-43Cr	-47Cr	-18Cr	10Cr
Net Income to Common Excl. Extra Items	162.44Cr	-43Cr	-47Cr	-18Cr	10Cr
Per Share Items
Net EPS - Basic	3.27	-0.85	-0.94	-0.35	0.19
Basic EPS - Continuing Operations	3.27	-0.85	-0.94	-0.35	0.19
Basic Weighted Average Shares Outstanding	50Cr	51Cr	50Cr	51Cr	52Cr
Net EPS - Diluted	3.09	-0.85	-0.94	-0.35	0.19
Diluted EPS - Continuing Operations	3.09	-0.85	-0.94	-0.35	0.19
Diluted Weighted Average Shares Outstanding	53Cr	51Cr	50Cr	51Cr	53Cr
Normalized Basic EPS	2.28	-0.06	-0.38	0.02	0.22
Normalized Diluted EPS	2.15	-0.06	-0.38	0.02	0.22
Dividend Per Share	0.38	-	-	-	-
Payout Ratio	12.15	-46.78	-	-	-
Supplemental Items
Total Revenues (As Reported)	250.4Cr	158.69Cr	80Cr	84Cr	119.81Cr
Effective Tax Rate - (Ratio)	11.34	-18.53	-35.33	-29.58	42.99
Current Domestic Taxes	14Cr	6.26Cr	9.15Cr	4.05Cr	3.52Cr
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	14Cr	6.26Cr	9.15Cr	4.05Cr	3.52Cr
Total Deferred Taxes	6.57Cr	83.99L	2.89Cr	75.52L	3.44Cr
Normalized Net Income	112.92Cr	-3.13Cr	-19Cr	86.87L	11Cr
Supplemental Operating Expense Items
Stock-Based Comp., G&A Exp. (Total)	6.27Cr	11Cr	6.14Cr	3.88Cr	3.14Cr
Total Stock-Based Compensation	6.27Cr	11Cr	6.14Cr	3.88Cr	3.14Cr

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Assets
Cash And Equivalents	238.16Cr	153.77Cr	111.02Cr	129.84Cr	135.54Cr
Cash & Securities Segregated	121.11Cr	74Cr	27Cr	156.34Cr	77Cr
Securities Purchased Under Agreements To Resell	11Cr	47.15L	-	1.9Cr	-
Accounts Receivable, Total	39Cr	129.87Cr	151.01Cr	65Cr	44Cr
Other Receivables	9.98Cr	114.84Cr	7.88Cr	12Cr	5.37Cr
Gross Property Plant And Equipment	49Cr	47Cr	45Cr	32Cr	33Cr
Accumulated Depreciation	-31Cr	-34Cr	-38Cr	-26Cr	-29Cr
Net Property Plant And Equipment	18Cr	13Cr	6.95Cr	5.71Cr	4.18Cr
Other Intangibles, Total	8.9Cr	12Cr	10Cr	7.36Cr	5.72Cr
Investment In Debt and Equity Securities	439.5Cr	240.7Cr	151.84Cr	226.31Cr	226.24Cr
Trading Asset Securities, Total	289.41Cr	331.58Cr	300.32Cr	300.85Cr	310.43Cr
Other Current Assets, Total	57Cr	69Cr	17Cr	28Cr	40Cr
Deferred Tax Assets Long-Term (Collected)	17Cr	16Cr	12Cr	9.21Cr	5.77Cr
Other Long-Term Assets, Total	167.83Cr	152.34Cr	137.97Cr	113.37Cr	109.07Cr
Total Assets	1.42TCr	1.31TCr	934.04Cr	1.06TCr	962.99Cr
Liabilities
Accounts Payable, Total	143.3Cr	171.95Cr	90Cr	206.46Cr	105.16Cr
Accrued Expenses, Total	77Cr	44Cr	16Cr	10Cr	13Cr
Short-Term Borrowings	92Cr	39Cr	58Cr	59Cr	39Cr
Current Portion of Long-Term Debt	59Cr	61Cr	-	-	-
Current Portion of Leases	5.74Cr	5.54Cr	3.55Cr	2.07Cr	2.08Cr
Long-Term Debt	162.58Cr	151.26Cr	-	-	-
Long-Term Leases	9.46Cr	5.45Cr	1.75Cr	2.18Cr	1.18Cr
Current Income Taxes Payable	18Cr	13Cr	11Cr	7.39Cr	6.2Cr
Unearned Revenue, Current	5.97Cr	2.37Cr	1.66Cr	1.37Cr	2.19Cr
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	45Cr	52Cr	28Cr	58Cr	79Cr
Unearned Revenue Non Current	66.71L	59.16L	4L	10.36L	8L
Deferred Tax Liability Non-Current	7.22Cr	7.21Cr	6.05Cr	3.75Cr	3.81Cr
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	625.67Cr	553.83Cr	216.34Cr	351.18Cr	252.66Cr
Common Stock, Total	90T	93T	93T	94T	94T
Additional Paid In Capital	621.13Cr	610.44Cr	616.5Cr	625.66Cr	632.04Cr
Retained Earnings	110.38Cr	67Cr	20Cr	2.3Cr	12Cr
Treasury Stock	-6T	-8T	-8T	-8T	-8T
Comprehensive Income and Other	-49Cr	-28Cr	-23Cr	-24Cr	-34Cr
Total Common Equity	682.6Cr	650.15Cr	613.94Cr	604.36Cr	610.93Cr
Minority Interest	108.15Cr	103.78Cr	103.75Cr	100.52Cr	99Cr
Total Equity	790.75Cr	753.93Cr	717.69Cr	704.88Cr	710.33Cr
Total Liabilities And Equity	1.42TCr	1.31TCr	934.04Cr	1.06TCr	962.99Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	55Cr	57Cr	57Cr	57Cr	57Cr
ECS Total Common Shares Outstanding	55Cr	57Cr	57Cr	57Cr	57Cr
Book Value / Share	12.4	11.44	10.8	10.56	10.66
Tangible Book Value	673.71Cr	638.25Cr	603.66Cr	597Cr	605.21Cr
Tangible Book Value Per Share	12.24	11.23	10.62	10.43	10.56
Total Debt	328.64Cr	262.1Cr	63Cr	64Cr	43Cr
Net Debt	-330.95Cr	-297.54Cr	-375.69Cr	-525.27Cr	-480.62Cr
Equity Method Investments, Total	165.92Cr	141.8Cr	129.17Cr	109.96Cr	107.76Cr
Full Time Employees	737	754	566	480	443
Accumulated Allowance for Doubtful Accounts (Supple)	9L	9.22Cr	12Cr	36.03L	1.02Cr

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Net Income	162.44Cr	-43Cr	-47Cr	-18Cr	10Cr
Depreciation, Depletion & Amortization	7.79Cr	6.87Cr	6.07Cr	5.1Cr	3.15Cr
Total Depreciation, Depletion & Amortization	7.79Cr	6.87Cr	6.07Cr	5.1Cr	3.15Cr
Amortization of Deferred Charges, Total	1.28Cr	1.75Cr	2.79Cr	2.81Cr	2.33Cr
(Gain) Loss On Sale of Asset - (CF)	44T	48T	28T	-4T	55T
(Gain) Loss on Sale of Investments - (CF)	-88Cr	15Cr	20Cr	5.16Cr	-15Cr
Total Asset Writedown	-	-	-	-1.84Cr	-4.93Cr
Provision for Credit Losses	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	1.44Cr	62.44L	-13.86L	-5L	-
Stock-Based Compensation (CF)	6.27Cr	11Cr	6.14Cr	3.88Cr	3.14Cr
Provision and Write-off of Bad Debts	4.64Cr	24Cr	1.68Cr	-	-
Change in Trading Asset Securities	111.11Cr	-25Cr	36Cr	16Cr	88.77L
Change in Accounts Receivable	183.07Cr	-53Cr	40Cr	13Cr	21Cr
Change in Accounts Payable	-71Cr	20Cr	-127.92Cr	115.87Cr	-69Cr
Change in Unearned Revenues	1.24Cr	-3.67Cr	-1.27Cr	-22.51L	80.19L
Change in Other Net Operating Assets (Collected)	-84Cr	-37Cr	122.38Cr	-132.72Cr	41Cr
Other Operating Activities	-66Cr	7.79Cr	21Cr	-4.4Cr	2.26Cr
Cash from Operations	169.78Cr	-74Cr	79Cr	4.3Cr	-2.76Cr
Capital Expenditure	-2.67Cr	-40.49L	-11.83L	-1.61Cr	-28.51L
Sale of Property, Plant, and Equipment	17T	15T	10.62L	1.06Cr	44.7L
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	-	-
Purchase / Sale of Intangible Assets	-3.07Cr	-4.75Cr	-1.17Cr	-35L	-70.46L
Investment in Marketable and Equity Securities, Total	-158.44Cr	51Cr	105.46Cr	-1.21Cr	7.94Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	58Cr	-17Cr	1Cr	-	13Cr
Other Investing Activities, Total	3.85Cr	3.65Cr	7.49Cr	-1.27Cr	-13Cr
Cash from Investing	-102.82Cr	33Cr	112.76Cr	-3.37Cr	7.06Cr
Short Term Debt Issued, Total	-	-	-	-	21Cr
Long-Term Debt Issued, Total	283.89Cr	92Cr	16Cr	-	-
Total Debt Issued	283.89Cr	92Cr	16Cr	-	21Cr
Short Term Debt Repaid, Total	-31Cr	-	-	-	-
Long-Term Debt Repaid, Total	-61Cr	-115.83Cr	-247.59Cr	-14Cr	-2.53Cr
Total Debt Repaid	-92Cr	-115.83Cr	-247.59Cr	-14Cr	-2.53Cr
Issuance of Common Stock	4.54Cr	2.2Cr	-	63.76L	19.15L
Repurchase of Common Stock	-9.98Cr	-8.3Cr	-	-	-
Issuance of Preferred Stock	-	-	-	-	-
Common Dividends Paid	-20Cr	-20Cr	-	-	-
Common & Preferred Stock Dividends Paid	-20Cr	-20Cr	-	-	-
Other Financing Activities, Total	-55Cr	-11Cr	-9.29Cr	27Cr	-10Cr
Cash from Financing	111.73Cr	-62Cr	-240.8Cr	14Cr	8.64Cr
Foreign Exchange Rate Adjustments	-5.19Cr	19Cr	6.21Cr	4.21Cr	-7.23Cr
Net Change in Cash	173.49Cr	-84Cr	-43Cr	19Cr	5.7Cr
Supplemental Items
Cash Interest Paid	7.29Cr	9.28Cr	5.03Cr	35.9L	26.85L
Cash Income Tax Paid (Refund)	13Cr	11Cr	11Cr	7.42Cr	4.7Cr
Net Debt Issued / Repaid	191.45Cr	-24Cr	-231.51Cr	-14Cr	18Cr

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Profitability
Return on Assets	12.32	-3.33	-4.11	-2.12	0.91
Return On Equity %	21.52	-5.88	-6.26	-2.96	1.3
Return on Common Equity	25.54	-6.45	-7.47	-2.94	1.67
Margin Analysis
Gross Profit Margin %	100	100	100	100	100
SG&A Margin	46.73	55.5	66.47	59.07	34.97
Income From Continuing Operations Margin %	69.9	-33.41	-63.77	-25.58	7.42
Net Income Margin %	69.01	-31.64	-65.28	-21.74	8.15
Net Avail. For Common Margin %	69.01	-31.64	-65.28	-21.74	8.15
Normalized Net Income Margin	47.97	-2.3	-26.47	1.05	9.24
Asset Turnover
Asset Turnover	0.18	0.1	0.06	0.08	0.12
Short Term Liquidity
Current Ratio	1.72	2.24	2.95	2.01	2.47
Quick Ratio	1.59	2.07	2.87	1.93	2.31
Operating Cash Flow to Current Liabilities	0.38	-0.19	0.38	0.01	-0.01
Long Term Solvency
Total Debt/Equity	41.56	34.76	8.77	9.03	5.99
Total Debt / Total Capital	29.36	25.8	8.06	8.28	5.65
LT Debt/Equity	21.76	20.78	0.24	0.31	0.17
Long-Term Debt / Total Capital	15.37	15.42	0.22	0.28	0.16
Total Liabilities / Total Assets	44.17	42.35	23.16	33.25	26.24
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-13.37	-42.27	-46.8	13.92	51.07
Gross Profit, 1 Yr. Growth %	-13.37	-42.27	-46.8	13.92	51.07
Earnings From Cont. Operations, 1 Yr. Growth %	60.64	-127.59	1.55	-54.3	-143.82
Net Income, 1 Yr. Growth %	56.53	-126.47	9.77	-62.06	-156.63
Normalized Net Income, 1 Yr. Growth %	37.47	-102.77	511.55	-104.4	1.22T
Diluted EPS Before Extra, 1 Yr. Growth %	56.06	-127.51	10.59	-62.77	-154.29
Common Equity, 1 Yr. Growth %	15.78	-4.75	-5.57	-1.56	1.09
Total Assets, 1 Yr. Growth %	12.98	-7.67	-28.58	13.06	-8.81
Tangible Book Value, 1 Yr. Growth %	15.66	-5.26	-5.42	-1.1	1.38
Cash From Operations, 1 Yr. Growth %	399.13	-143.47	-207.14	-94.57	-164.33
Capital Expenditures, 1 Yr. Growth %	243.95	-84.82	-70.78	1.26T	-82.24
Dividend Per Share, 1 Yr. Growth %	0	-	-	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	20.7	-29.28	-44.58	-22.15	31.19
Gross Profit, 2 Yr. CAGR %	20.7	-29.28	-44.58	-22.15	31.19
Earnings From Cont. Operations, 2 Yr. CAGR %	130.29	-33.42	-47.07	-31.88	-55.25
Net Income, 2 Yr. CAGR %	156.56	-35.64	-46.1	-35.47	-53.65
Normalized Net Income, 2 Yr. CAGR %	114.04	-80.48	-58.83	-47.31	-23.66
Diluted EPS Before Extra, 2 Yr. CAGR %	159.18	-34.48	-44.84	-35.83	-55.04
Common Equity, 2 Yr. CAGR %	15.03	5.01	-5.16	-3.59	-0.25
Total Assets, 2 Yr. CAGR %	22.04	2.13	-18.79	-10.14	1.54
Tangible Book Value, 2 Yr. CAGR %	14.85	4.68	-5.34	-3.29	0.13
Cash From Operations, 2 Yr. CAGR %	97	47.3	-31.76	-75.87	-81.31
Capital Expenditures, 2 Yr. CAGR %	57.26	-27.75	-78.94	99.11	55.24
Dividend Per Share, 2 Yr. CAGR %	59.16	-	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	19.4	-5.61	-35.68	-29.54	-2.9
Gross Profit, 3 Yr. CAGR %	19.4	-5.61	-35.68	-29.54	-2.9
Earnings From Cont. Operations, 3 Yr. CAGR %	-0.12	13.53	-23.36	-49.6	-41.2
Net Income, 3 Yr. CAGR %	0.1	20.32	-23.1	-52.06	-38.22
Normalized Net Income, 3 Yr. CAGR %	59.14	-49.74	-38.47	-80.26	54.29
Diluted EPS Before Extra, 3 Yr. CAGR %	-15.66	22.71	-21.99	-51.62	-39.31
Common Equity, 3 Yr. CAGR %	11.39	8.01	1.36	-3.98	-2.05
Total Assets, 3 Yr. CAGR %	24.64	11.2	-9.35	-9.32	-9.7
Tangible Book Value, 3 Yr. CAGR %	11.16	7.71	1.2	-3.95	-1.76
Cash From Operations, 3 Yr. CAGR %	2.01	19.04	32.47	-70.64	-66.55
Capital Expenditures, 3 Yr. CAGR %	32.16	-27.86	-46.57	-15.58	-11.04
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	22.68	7.42	-12.17	-12.61	-14.46
Gross Profit, 5 Yr. CAGR %	22.68	7.42	-12.17	-12.61	-14.46
Earnings From Cont. Operations, 5 Yr. CAGR %	55.42	37.27	-22.52	-7.45	-38.2
Net Income, 5 Yr. CAGR %	51.69	354.89	-21.86	-6.22	-37.2
Normalized Net Income, 5 Yr. CAGR %	36.8	-26.09	-7.34	-48.78	-32.52
Diluted EPS Before Extra, 5 Yr. CAGR %	32.87	301.57	-28.84	-5.32	-37.42
Common Equity, 5 Yr. CAGR %	227.5	128.06	4.45	3.22	0.71
Total Assets, 5 Yr. CAGR %	43.3	20.64	5.01	2.12	-5.14
Tangible Book Value, 5 Yr. CAGR %	318.21	143.2	4.24	3.17	0.77
Cash From Operations, 5 Yr. CAGR %	27.93	67.79	-13.14	-37.13	-39.47
Capital Expenditures, 5 Yr. CAGR %	-14.06	-33.63	-36.61	8.27	-18.14